[19] |
1 |
China |
55 d |
F |
Tachycardia, respiratory distress, pharyngeal hyperemia, cough |
NA |
NA |
Troponin, CK-MB, procalcitonin |
Ground-glass opacities, pneumonia |
IVIG, inhaled interferon alfa 1b, glutathione, Chinese lotus qingwen |
Survived |
[20] |
1 |
China |
13 m |
M |
Cough, crackles |
NA |
Heart failure |
CRP, creatinine kinase, D-dimer, IL6, interferon-gamma, |
Multiple patch-like shadows, pneumonia |
Virazole, oseltamivir, interferon, IVIG, steroids, oxygen therapy, mechanical ventilation |
Survived |
[21] |
9 |
China |
11 m-10 y |
3M |
Productive cough |
NA |
NA |
CK-MB, Pro-BNP, D-dimer |
Pulmonary consolidation, ground-glass opacities |
Inhaled interferon, ribavirin, lopinaviritonavir |
NA |
[17] |
13/2135 |
China |
0–18 y |
12M |
NA |
NA |
Heart failure |
NA |
NA |
NA |
NA |
[22] |
3 |
USA |
6–13 y |
2M |
Tachycardia, tachypnea, hypotension, systolic murmur, dyspnea |
Sinus tachycardia |
Depressed function, MR, flow reversal in descending aorta, pericardial effusion |
Procalcitonin, D-dimer, fibrinogen, troponin, CRP, LDH |
NA |
IL6 inhibitor, IVIG, hydroxychloroquine |
Survived |
[23] |
21 |
France |
3–17 y |
9M |
Cough |
QT prolongation, ST-segment elevation, ventricular arrhythmia |
Coronary artery dilatation, myocarditis, pleural effusion, depressed ejection fraction |
CRP, procalcitonin, IL6, Pro-BNP, D-dimer |
Local patchy shadows, ground-glass opacities, interstitial abnormalities |
IVIG, aspirin, corticosteroids, inotropes, oxygen support, mechanical ventilation |
Survived |
[24] |
1 |
USA |
6 y |
F |
Syncope, respiratory distress, hypotension |
Junctional rhythm |
Depressed ejection function, MR |
CRP, procalcitonin, Pro-BNP, D-dimer |
Diffuse patchy infiltrates |
Aspirin, IVIG, inotropic support, oxygen support, ECMO |
Survived |
[25] |
99 |
USA |
0–20 y |
53M |
Hypotension, cough, shortness of breath, wheezing |
NA |
Ventricular dysfunction, pericardial effusion, CAA |
Troponin, Pro-BNP, D-dimer, CRP, fibrinogen, ferritin, ESR |
Opacities, pleural effusion |
Corticosteroids, IVIG, oxygen support, inotropic support, ECMO |
2/99 died |
[26] |
186 |
USA |
0–20 y |
115M |
NA |
NA |
Coronary artery dilatation, CAA, depressed EF, pericardial effusion |
Pro-BNP, troponin, D-dimer, fibrinogen, INR |
NA |
IL6 inhibitors, IL1Ra inhibitor, IVIG, corticosteroids mechanical ventilation, ECMO, vasopressor support, oxygen support |
4/186 died |
[27] |
15 |
USA |
3–20 y |
11M |
Cough, dyspnea, chest pain, tachycardia, hypotension |
Ventricular tachycardia, and ectopy, diffuse ST elevation |
Depressed LV/biventricular function, coronary artery ectasia and dilatation, cardiogenic shock |
Troponin, Pro-BNP, fibrinogen, CRP, D-dimer, procalcitonin, IL6, IL8, TNF alfa |
Ground-glass opacities, pleural effusion |
IVIG, steroids, anakinra, remdesivir, inotropic support, anticoagulation, mechanical ventilation, ECMO, intraaortic balloon pump, tocilizumab, COVID-19 convalescent plasma, |
1/15 died |
[28] |
5 |
France and Switzerland |
2–16 y |
18M |
Respiratory distress, chest pain |
Ventricular arrhythmia, nonspecific ST elevation |
Cardiogenic shock, LV dysfunction and hypokinesis, coronary artery dilatation, pericardial effusion |
Troponin, creatinine kinase, Pro-BNP, D-dimer, CRP, procalcitonin, IL6 |
NA |
Inotropic support, mechanical ventilation, ECMO, IVIG, steroids, anakinra |
Survival |
[29] |
4 |
USA |
3–20 y |
3M |
Tachycardia |
Low voltage nonspecific T-wave changes, right axis deviation, ST-segment elevation, QTc prolongation |
Myocarditis, MR, depressed LV and RV functions, pericardial effusion |
CRP, ferritin, troponin, pro-BPN, D-dimer, ferritin, fibrinogen |
NA |
IVIG, anticoagulation, tocilizumab, convalescent plasma, mechanical ventilation, ECMO |
1/4 died |
[30] |
1 |
USA |
6 m |
F |
Tachycardia, tachypnea |
NA |
Normal |
ESR, CRP |
Opacities |
Aspirin, IVIG |
Survived |
[31] |
156 |
France |
5–11 y |
77M |
NA |
NA |
Myocarditis |
NA |
NA |
Mechanical ventilation, inotropic support |
1/156 died |